![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Press Releases
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
Ufovax, a spin-off vaccine company from Scripps Research, announced that the company has successfully extended its patented one component self-assembling protein nanoparticle (1c-SApNP) vaccine...
Clinical Trials
CluePoints Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has seen a dramatic...
News
Roches cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test. It is...
Drug Research
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its...
News
COVID-19 and the pharma supply chain – How to manage your pharmaceutical logistics in difficult times
With panic buying of face masks and no hand sanitiser on chemists’ shelves, there is no doubt that the latest COVID-19 outbreak is having...
News
FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19
Thermo Fisher Scientific Inc., the world leader in serving science, announced that the U.S. Food and Drug Administration (FDA) has issued an emergency use...
News
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
BioNTech SE provides further details on the Company’s R&D effort, “Project Lightspeed”, to develop a potential vaccine to induce immunity and prevent COVID-19 infection...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read